150 related articles for article (PubMed ID: 2305464)
1. Causes of graft loss beyond two years in the cyclosporine era.
Dunn J; Golden D; Van Buren CT; Lewis RM; Lawen J; Kahan BD
Transplantation; 1990 Feb; 49(2):349-53. PubMed ID: 2305464
[TBL] [Abstract][Full Text] [Related]
2. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
3. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
[TBL] [Abstract][Full Text] [Related]
4. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?
Marcén R; Pascual J; Teruel JL; Villafruela JJ; Rivera ME; Mampaso F; Burgos FJ; Ortuño J
Transplantation; 2001 Jul; 72(1):57-62. PubMed ID: 11468535
[TBL] [Abstract][Full Text] [Related]
5. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
Sumrani N; Delaney V; Ding ZK; Butt K; Hong J
Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for second renal allografts immunosuppressed with cyclosporine.
Almond PS; Matas AJ; Gillingham K; Troppmann C; Payne W; Dunn D; Sutherland D; Najarian JS
Transplantation; 1991 Aug; 52(2):253-8. PubMed ID: 1871798
[TBL] [Abstract][Full Text] [Related]
8. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
Cecka JM
Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
[TBL] [Abstract][Full Text] [Related]
9. Impact of cyclosporine on renal transplant practice at the University of Texas Medical School at Houston.
Kahan BD; Kerman RH; Wideman CA; Flechner SM; Jarowenko M; Van Buren CT
Am J Kidney Dis; 1985 Jun; 5(6):288-95. PubMed ID: 3925760
[TBL] [Abstract][Full Text] [Related]
10. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction.
Pascual J; Marcén R; Orofino L; Quereda C; Mampaso F; Liaño F; Ortuño J
Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
[TBL] [Abstract][Full Text] [Related]
12. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches.
Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
Transplantation; 1985 Dec; 40(6):615-9. PubMed ID: 3907031
[TBL] [Abstract][Full Text] [Related]
13. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
14. Renal transplantation at the University of Wisconsin in the cyclosporine era.
Knechtle SJ; Pirsch JD; D'Alessandro AM; Sollinger HW; Kalayoglu M; Belzer FO
Clin Transpl; 1993; ():211-8. PubMed ID: 7918154
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
[TBL] [Abstract][Full Text] [Related]
16. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
Kupin WL; Venkatachalam KK; Oh HK; Dienst S; Levin NW
Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029
[TBL] [Abstract][Full Text] [Related]
17. Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.
Tilney NL; Chang A; Milford EL; Whitley WD; Lazarus JM; Ramos EL; Strom TB; Carpenter CB; Kirkman RL
Ann Surg; 1991 Jul; 214(1):42-9. PubMed ID: 2064470
[TBL] [Abstract][Full Text] [Related]
18. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
[TBL] [Abstract][Full Text] [Related]
19. Spanish experience with cyclosporine.
Pascual J; Marcén R; Burgos FJ; Villafruela JJ; Teruel JL; Mampaso F; Quereda C; Ortuño J
Transplant Proc; 2004 Mar; 36(2 Suppl):117S-119S. PubMed ID: 15041319
[TBL] [Abstract][Full Text] [Related]
20. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
Vathsala A; Woo KT
Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
